Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxiteno is a Brazilian-founded specialty chemicals company best known for producing surfactants and related chemical intermediates for consumer and industrial end markets. Historically operated as Oxiteno S.A. Indústria e Comércio, the business was acquired by Indorama Ventures in April 2022 and now sits within Indovinya, Indorama's specialty chemical and surfactants division. Oxiteno's portfolio serves applications such as personal care, home care, crop solutions, coatings, energy and industrial markets rather than biopharma therapeutics. The company has manufacturing, R&D, and commercial operations across the Americas and other international markets, with particular strength in ethoxylation, specialty surfactants, and sustainable formulation ingredients. For a biotech or healthcare analyst, Oxiteno is best understood as an industrial and specialty ingredients supplier that may touch health-adjacent markets like personal care and nutrition, but it is not a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxiteno.